Loading...

The combination of neoantigen quality and T lymphocyte infiltrates identifies glioblastomas with the longest survival

Glioblastoma (GBM) is resistant to multimodality therapeutic approaches. A high burden of tumor-specific mutant peptides (neoantigens) correlates with better survival and response to immunotherapies in selected solid tumors but how neoantigens impact clinical outcome in GBM remains unclear. Here, we...

Full description

Saved in:
Bibliographic Details
Published in:Commun Biol
Main Authors: Zhang, Jing, Caruso, Francesca P., Sa, Jason K., Justesen, Sune, Nam, Do-Hyun, Sims, Peter, Ceccarelli, Michele, Lasorella, Anna, Iavarone, Antonio
Format: Artigo
Language:Inglês
Published: Nature Publishing Group UK 2019
Subjects:
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6478916/
https://ncbi.nlm.nih.gov/pubmed/31044160
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s42003-019-0369-7
Tags: Add Tag
No Tags, Be the first to tag this record!